Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × High-Risk Cancer × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 596 Carcinoma, Non-Small-Cell Lung 409 Prostatic Neoplasms 346 Neoplasms 344 Lung Neoplasms 222 Multiple Myeloma 218 Colorectal Neoplasms 201 Neoplasm Metastasis 186 Melanoma 180 Leukemia, Myeloid, Acute 156 Ovarian Neoplasms 149 Pancreatic Neoplasms 138 Squamous Cell Carcinoma of Head and Neck 126 Brain Neoplasms 126 Lymphoma 123 Glioblastoma 122 Carcinoma, Renal Cell 119 Recurrence 115 Leukemia, Lymphocytic, Chronic, B-Cell 114 Lymphoma, Non-Hodgkin 112 Carcinoma, Hepatocellular 107 Precursor Cell Lymphoblastic Leukemia-Lymphoma 101 Triple Negative Breast Neoplasms 98 Head and Neck Neoplasms 97 Urinary Bladder Neoplasms 90 Lymphoma, Large B-Cell, Diffuse 88 Hematologic Neoplasms 88 Stomach Neoplasms 87 Sarcoma 84 Colonic Neoplasms 83

Interventions

Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978663 2026-02-20

TRIO

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Active not recruiting

High-Risk Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡